EUCTR2015-002987-17-ES进行中（未招募）不适用
inezolid continuous infusion: optimizing the dosage regimen in critically ill patients through a pharmacokinetic / pharmacodynamic analysis
Helena Barrasa0 个研究点开始时间: 2015年11月5日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Admitted to the intensive care unit.
- •Diagnosis of sepsis.
- •Need to linezolid because of suspected infection due to multiresistant gram positive cocci
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Pregnancy. Age <18 years. Severe renal failure
研究者
相似试验
尚未招募
不适用
Defining the optimal dose for continuous flucloxacillin infusioNL-OMON28330Deventer Hospital30
已完成
不适用
Optimizing endoxifen concentration through the induction of CYP3A4, CYP2C and CYP2D6 mediated tamoxifen metabolism10006291Breast cancerNL-OMON38337Erasmus MC, Universitair Medisch Centrum Rotterdam12
招募中
Unknown
Clinical implementation of the infusion rate individualization of intravenous lipid emulsioJPRN-UMIN000054236Kobe Gakuin University120
已完成
不适用
Application of a long acting insulin (glargine) in total parenteral nutritioTotal Parenteral Nutrition.Endocrine, nutritional and metabolic diseasesE89.8, E46IRCT2013072314121N1Deputy of Research, Tehran University of Medical Sciences28
尚未招募
不适用
Aproach to optimize the dose of contrasut medicum considering patient's blood flow on CTA.JPRN-UMIN000027046Ryukyu unversity hospital50